{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "effect is also represented in the corresponding figure . The\n\nabove compounds can be provided in any salt form suitable\n\nfor administration or use .\n\n[ 0068 ]\n\nIt would be appreciated that the above compounds\n\nmay be used alone for treating or preventing RNA virus\n\ninfection such as flavivirus infection as they demonstrated\n\n.NH\n\nantiviral effect particularly by inhibiting the entry of flavi\n\nvirus into host cells . Therefore , the present invention also\n\npertains to a method of preventing or treating a subject\n\nsuffering from a flavivirus infection by administering the\n\nsubject with an effective amount of a compound selected\n\nfrom the group consisting of the following compounds and\n\n?? , ,\n\na derivative thereof :\n\nDom\n\nMar. 4, 2021\n\nUS 2021/0060002 A1\n\n-continued\n\n-continued\n\n[0067] The above compounds were identified and consid- ered to have a similar 3D conformation with berbamine. Particularly, these compounds were identified using berbam- ine as reference and therefore it is believed that they can achieve similar or identical inhibitory effect as berbamine. It has also been determined that the above compounds have anti-viral effect, which is described in the examples and the effect is also represented in the corresponding figure. The above compounds can be provided in any salt form suitable for administration or use.\n\n[0068] It would be appreciated that the above compounds may be used alone for treating or preventing RNA virus infection such as flavivirus infection as they demonstrated antiviral effect particularly by inhibiting the entry of flavi- virus into host cells. Therefore, the present invention also pertains to a method of preventing or treating a subject suffering from a flavivirus infection by administering the subject with an effective amount of a compound selected from the group consisting of the following compounds and a derivative thereof:\n\nUS 2021/0060002 A1\n\nMar. 4 , 2021\n\n7\n\ncontinued\n\ncontinued\n\ngood OH\n\nBr\n\nand\n\nO ,", "type": "Document"}}